Hawkins (HWKN) is back in focus after reporting record first quarter revenue of US$315.7 million, a small year over year decline in earnings per share, and a 5% increase in its quarterly dividend.

The earnings miss and softer EPS appear to be weighing on sentiment, with Hawkins’ share price down 17.2% over the past 90 days and its 1 year total shareholder return down 12.5%. However, 3 and 5 year total shareholder returns remain very strong multiples of the starting point.

If earnings quality, dividends and long term compounding are on your radar, it can help to widen the lens beyond one stock and review a 19 top founder-led companies

After Hawkins’ sharp pullback despite record revenue and a higher dividend, investors now have to judge the recent valuation reset. Has most of the easy return already played out, or is there meaningful upside still on the table?

Price-to-Earnings of 35.5x: Is it justified?

Hawkins closed at $138.60 with a P/E of 35.5x, which points to a rich valuation compared to both the Chemicals industry and its closest peers.

The P/E ratio compares the current share price to the company’s earnings per share. For a business like Hawkins with established operations across water treatment, food and health sciences, and industrial solutions, this ratio reflects how much investors are currently paying for each dollar of earnings.

At 35.5x earnings, Hawkins trades well above the US Chemicals industry average P/E of 25.2x and above the peer average of 23.7x. It is also high relative to the estimated fair P/E of 18.4x that the SWS model suggests the market could gravitate toward over time. This highlights how much of a premium is currently embedded in the share price.

Result: Price-to-Earnings of 35.5x (OVERVALUED)

However, Hawkins’ premium P/E could compress if recent EPS softness persists or if demand across water treatment, food and health sciences, and industrial customers weakens.

Another View on Hawkins Using the SWS DCF Model

While the 35.5x P/E makes Hawkins look expensive next to the Chemicals industry, the SWS DCF model paints a different picture. On that framework, Hawkins at $138.60 sits about 5.8% below an estimated fair value of $147.20. That suggests the recent sell off may already reflect a lot of the near term concern. The question is which signal you trust more when earnings momentum is mixed.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hawkins for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of concern and optimism around Hawkins feels familiar, take a moment to review the key data points yourself and decide where you stand, then use the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Hawkins?

If you want Hawkins to be just one part of a stronger portfolio, now is the time to scan the market for other high quality opportunities using focused screeners.

• Target potential mispricings by reviewing companies highlighted in the 49 high quality undervalued stocks.
• Strengthen your income stream by assessing stocks featured in the 9 dividend fortresses.
• Prioritize resilience by checking companies surfaced in the 85 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.